Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Vicore Pharma receives approval to start Phase IIa study in IPF

Vicore Pharma Holding (publ) (ticker: VICO) today announces the approval from the British Medicines Agency MHRA and the Ethics Committee for London and Surrey to conduct a Phase IIa study on IPF"We are very pleased with this important approval and we are looking forward to starting the study together with our clinical research partners at different hospitals and with PAREXEL. This approval marks one of the biggest milestones so far in the company's development." says Per Jansson, CEO The Phase IIa study is a double-blind and placebo-controlled study that will include 15+15 patients,

Fatty fish and camelina oil are beneficial for your HDL and IDL cholesterol

Eating fatty fish increases the size and lipid composition of HDL particles in people with impaired glucose metabolism, according to a new study from the University of Eastern Finland. These changes in the size and lipid composition of HDL particles make them beneficial for cardiovascular health. Published in Molecular Nutrition & Food Research, the study also found that camelina sativa oil decreases the number of harmful IDL particles. The researchers studied the effects of camelina oil and fatty fish intake on the size and composition of cholesterol-carrying lipoproteins. The HDL

Teleste introduces S-AWARE®,a smart platform for situational awareness and incident management that goes beyond traditional video surveillance systems

Teleste’s new S-AWARE® platform adds an advanced layer of intelligence and data analysis capabilities to existing security and operations control systems. Increasing awareness of your surroundings and helping control events and incidents, the solution provides operating personnel with an invaluable tool for sharper decision-making. Turku, Finland –  18 April 2018 – Teleste Corporation will launch a new solution for situational awareness and incident management at Securex 2018 in Poland. The solution, called S-AWARE®, has been designed to expand the scope of traditional security and

Invitation to conference call on three-month interim report 2018

Beijer Electronics Group AB (publ) releases its interim report for January−March 2018 on Thursday, April 26, 2018, at 1.00 p.m. CEST.On the same day, a conference call will be held for press and analysts, where President and CEO Per Samuelsson and Executive VP and CFO Joakim Laurén present the company and comment on the report. Time:  Thursday April 26, at 2.00 p.m. CEST To participate in the conference please dial: From SE: +46851999031From UK: +442030089804   To access the presentation please use this link: http://www.anywhereconference.com?UserAudioMode=DATA&Name=&

Pirate Fishing Tycoon Hit with 8.2 Million Euro Fine in Spain

FOR IMMEDIATE RELEASE 18 April 2018 Florindo González Corral, the Spanish fishing tycoon who owned the world’s most infamous pirate fishing vessel, the F/V Thunder, has been fined 8.2 million euros in a civil case brought by the Spanish government. The F/V Thunder was an INTERPOL-wanted fishing vessel that was involved in more than 10 years of illegal fishing in the Southern Ocean before its captain deliberately sank the vessel in the Gulf of Guinea after a 110-day at-sea pursuit by Sea Shepherd vessels. The captain and two of his crew, who were rescued by Sea Shepherd, were

Bona introduces new brush technology that enables exciting wood floor effects

Bona, the leading name in wood floor treatment, introduces a new brush technology that allows professionals to enhance the natural character of wood and create inspirational new looks with ease. With a century-long dedication and passion for wooden floors, Bona has developed an innovative system for creating exciting flooring effects as a part of the Bona Inspiration concept - a floor styling program with inspiration and guidance in flooring trends. New Bona Brush Technology is a unique system that allows the contractor to renovate existing floors to create new, trendy effects,

Fabege AB (publ) executes share split

The Annual General Meeting in Fabege AB (publ) held on 9 April 2018 resolved to increase the total number of shares in the company by dividing each share into two shares (a so called 2:1 share split). The Board of Directors was authorised to decide the record day for the share split.The Board of Directors has resolved that the record day for the share split shall fall on 27 April 2018 and the new shares are expected to be registered in the shareholders’ accounts on 30 April 2018. Last day of trading with shares before the share split is 25 April 2018 and the first day of trading with

Bestic patent granted in China

The State Intellectual Property Office in China informs that they have granted patent for the assistive eating device Bestic®. The patent protects Camanio Care on one of the world’s most essential markets for welfare technology.According to the EU-project ”SILVER” (www.silverpcp.eu), around 0.2% of the adult population is being fed. This is equal to approximately 3 million individuals in China alone. The reasons behind eating difficulties are several. However, neurological diagnosis such as stroke, ALS, Parkinson and spinal cord lesion can cause eating difficulties. People suffering from

NeuroVive’s KL1333 receives FDA Orphan Drug Designation for treatment of mitochondrial diseases

Lund, Sweden, 18 April 2018 NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announced that it has been granted Orphan Drug Designation by the United States FDA Office of Orphan Products Development for its project KL1333 for treatment of inherited mitochondrial respiratory chain diseases (MRCD).Orphan drug designation (ODD) will give the KL1333 program extra access to regulatory and scientific advice and interactions at the FDA and may enable a focused development program and speedy approval process. ODD opens up for market

#18-655 No market making in certain ETPs

Due to technical problems on NASDAQ, issuers are not able to act as market makers in certain instruments. This affects mainly instruments with Nordic underlyings. The instruments concerned will be in an Order Protection Auction thus preventing any trades being executed until the market maker returns with prices. Market making will be resumed as soon as possible. For further information concerning this NGM notice please contact: NGM market surveillance, +46 8 566 390 55, marketsurveillance@ngm.se Nordic Growth Market NGM ABAbout NGM Nordic Growth Market NGM AB (NGM) is an

Preparing for commercialisation of Ygalo®

Stockholm - 18 April 2018 - Oncopeptides AB (Nasdaq Stockholm: ONCO) yesterday announced the notice for the AGM in which the Nomination Committee is proposing two new candidates for the Board of Directors. Per Wold-Olsen and Brian Stuglik will bring additional late-stage development and commercialisation experience to the company should the AGM vote in favour of the proposal. In conjunction with the AGM the proposal is furthermore that Alan Hulme will be stepping down as Chairman after eight successful years and handing over to Per Wold-Olsen as successor. Oncopeptides has over the last

Passenger volumes at Helsinki Airport increasing faster than at other Nordic main airports

In March, the growth of passenger traffic at the main Nordic airports was the fastest at Helsinki Airport for the eleventh consecutive month. The increase in passenger volumes also continues at other Finnish airports. In the first quarter of 2018, Finavia’s airports were visited by a little over 5.9 million passengers.“We carry out a monthly comparison of the growth rate of Helsinki Airport’s international passenger traffic to the reported growth of passenger volumes at other main airports in Northern Europe. In a long-term comparison, we surpassed Oslo in Norway and Copenhagen in Denmark

Concordia Maritime collaborates with the Swedish Institute for the Marine Environment to measure microplastics in the oceans

Together with the Swedish Institute for the Marine Environment, Concordia Maritime has initiated a preliminary study to determine the feasibility of gathering important information on the volume of micoplastics in the oceans. By installing a collection device on a tanker, water samples can be collected while it is under way for subsequent analysis by researchers. The aim is to draw conclusions as to the extent, distribution of microplastics and potential consequences for living organisms.In addition to the Swedish Institute for the Marine Environment, the preliminary study, which is

Change in number of shares in Camanio Care AB (publ)

Conversion of convertible notes into shares under the Convertible Notes issued within the financing agreement announced on December 6th 2017. The date of conversion was April 17th 2018 and the number of Notes converted was 40. The number of Notes remaining under the first Tranche for future conversion is 270. The number of shares and the number of votes before the conversion was 15 918 391. Through the conversion the number of shares and the number of votes has increased by 275 862. The total number of shares and the total number of votes after the conversion amount to 16 194 253.

ChromoGenics notice to Annual General Meeting 2018

Shareholders in ChromoGenics AB (publ) are hereby invited to the Annual General Meeting Wednesday May 16, 2018 at 14.00 CET at the offices of Law firm Lindahl, Vaksalagatan 10, Uppsala.NOTICE OF ANNUAL GENERAL MEETING IN CHROMOGENICS AB (PUBL) The shareholders in ChromoGenics AB (publ) reg. no. 556630-1809 (the “Company”) are hereby convened to the annual general meeting on Wednesday May 16, 2018, at 14.00 at the offices of Law firm Lindahl, Vaksalagatan 10, 751 42 Uppsala. Notice etc. Shareholders who wish to participate at the annual general meeting must: -  on Wednesday May 9,

First clinical study with CS1 completed

Cereno Scientific today announces that the company has completed its clinical study with drug candidate CS1. Preliminary analysis of the study data shows that CS1 was safe and well tolerated.The study was performed in collaboration with Cereno Scientific’s clinical research partner, CTC in Uppsala. In the study, individuals with an increased risk profile for thrombosis participated in evaluating safety, tolerability and pharmacokinetic properties of CS1. Furthermore, effects on risk markers for thrombosis were studied.Cereno continues to analyse all data from the study and hopes to be

Welcome to the Annual General Meeting (AGM) in Opus Group AB (PUBL)

Shareholders of Opus Group AB (publ) are hereby notified of the Annual General Meeting (AGM) to be held on Thursday, May 17, 2018, at 18.00, local time, at the Elite Park Avenue Hotel, Kungsportsavenyen 36, Gothenburg, Sweden. Registration for the AGM takes place from 17:00.NOTICE OF PARTICIPATION Shareholders wishing to participate in the AGM shall be registered in the Shareholders’ Register held by Euroclear Sweden AB as of Friday May 11, 2018, and have notified the company of their intention to attend by Friday May 11, 2018. Notification of participation at the AGM shall be made

Catarina Ihre proposed as a new member of Brighter's Board of Directors.

At Brighter's upcoming annual general shareholders meeting, the Company’s Nomination Committee will propose changes to the Board of Directors, with Catarina Ihre as a new member on the board. Catarina Ihre has worked as an analyst at Deutsche Bank and Nordea and in Investor Relations at Lundin Mining, SSAB and Electrolux. At Electrolux she held the position of VP Investor Relations.  "I look forward to working with Brighter, a visionary company with high ambitions in a very large market. Healthcare must be cheaper, more digital and help patients get higher quality of life. This is what

Notice of Paradox Interactive AB (publ)’s Annual General Meeting 2018

Shareholders in Paradox Interactive AB (publ), 556667-4759 are hereby invited to the Annual General Meeting (AGM) to be held May 18, 2018 13.00 CET at Scandic Malmen, Götgatan 49-51, 116 21 Stockholm.Please note that this is a translation for information purposes only – in case of any discrepancies between this version and the Swedish version, the Swedish version shall prevail. The Annual General Meeting will be held in Swedish only. Notice of attendance Shareholders who wish to attend the AGM shall: ·be entered in the company’s shareholders’ register kept by Euroclear Sweden

Invitation to conference call, April 25 at 2:30 pm CET

Studsvik AB presents its Interim Report for the first quarter 2018 and hereby invites media and analysts to a conference call held in English on Wednesday, April 25 at 2:30 pm CET.Studsvik’s Interim Report for the first quarter 2018 will be distributed at approximately 1.00 pm CET, April 25. As of this time, the report will also be available at www.studsvik.com. The call will be held in English, starting 2:30 pm CET. Please call at least ten minutes prior to the start of the conference call to avoid delay. Event title is: Studsvik Q1 2018. Conference ID is: 6783509  Description

Interim Report January-March 2018

First quarter 2018 compared to first quarter 2017 · Customer growth was 42,400 (38,400), which marked the second largest increase ever for a single quarter · Net inflow in the quarter was SEK 7,960 million, a decrease of 8 per cent · Operating income increased by 11 per cent, mainly due to higher fund volymes and, as a result, higher fund commissions. Other income also increased, mainly as a result of increased trading in foreign securities and higher income from Avanza Markets · Operating expenses increased by 23 per cent, mainly due to expanded development capacity for

Notice of annual general meeting in Scandi Standard AB (publ)

Scandi Standard AB (publ), 556921-0627, holds its annual general meeting on Tuesday 22 May 2018 at 1.00 p.m. CET at IVA Konferenscenter, Grev Turegatan 16 in Stockholm. The entrance to the meeting will open at noon CET. RIGHT TO PARTICIPATE AND NOTICE OF ATTENDANCE Those who wish to attend the annual general meeting must: · be entered as a shareholder in the share register kept by Euroclear Sweden AB on Wednesday 16 May 2018; and · give notice of attendance to the company no later than on Wednesday 16 May 2018. Notice of attendance may be given by telephone +46 (0)8 402 90

There are no items matching the current filter
There are no more items matching the current filter
Back to top